Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Ruanne V. Barnabas(Harvard University), Helen Y. Chu(Seattle Pacific University), Risa M. Hoffman(University of California, Los Angeles), Katherine K. Thomas(University of Namur), Helen C. Stankiewicz Karita(University of Washington), Keith R. Jerome(University of Washington), Meei‐Li Huang(Infectious Disease Research Institute), Susan Morrison, Miriam K. Laufer(University of Maryland, Baltimore), Harald S. Haugen, Patricia Kissinger(Tulane University), Raphael J. Landovitz(APLA Health), Michael K. Paasche‐Orlow(Tufts Medical Center), Kathleen M. Neuzil(Center for Global Development), Anna Wald(University of Washington), Mark H. Wener(University of Washington), Anna Bershteyn(New York University), Angelica C Kottkamp(New York University), Meagan E. Deming(University of Maryland, Baltimore), Lara Kidoguchi, Alexander L. Greninger(University of Washington), Jared M. Baeten(University of Washington), Kristopher Paolino(Walter Reed National Military Medical Center), Torin Schaafsma(University of Washington), Alfred Luk(Tulane University), Christine Johnston(University of Washington), Lorna E. Thorpe(New York State Department of State), Connie Celum(University of Washington), Meighan Krows, Elizabeth R. Brown(Fred Hutch Cancer Center)
Cited by 93
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|847